- JP-listed companies
- Kitazato Corporation
- Financials
- FCF margin (%)
Kitazato Corporation (368A)
Market cap
¥53.4B
P/E ratio
15.3x
Kitasato Corporation develops and manufactures medical devices and reagents for reproductive medicine including IVF and egg freezing, serving hospitals and clinics in over 110 countries worldwide.
| Period End | FCF margin (%) | YoY (%) |
|---|---|---|
| Mar 31, 2025 | 25.5 | -41.90% |
| Mar 31, 2024 | 43.9 | +99.74% |
| Mar 31, 2023 | 22 |